Allakos Closes $32M VC Round

Allakos Inc., a biotechnology company based in the San Francisco area, has raised $32 million in Series A venture financing. Novo Ventures led the round, with Alta Partners, RiverVest Venture Partners and the Roche Venture Fund also participating. As a result, Peter Moldt, partner at Novo Ventures; Robert Alexander, director at Alta Partners; and John McKearn, managing director at RiverVest Venture Partners, join the company’s board.

North AmericaUSBriefs